Hospira, Inc. (NYSE: HSP), announced today it will initiate a voluntary nationwide recall of one lot of 0.9 % Sodium Chloride Injection, USP, 250 mL (NDC 0409-7983-02, Lot 44 -002-JT, Expiry 1AUG2016) to the user level due to one confirmed customer report of
particulate in a single unit.